NOV (NOV) Stock Price Target 2026

The average analyst price target for NOV is $19.72, 11.5% above the current price. Of 15 analysts, 4 rate it Buy, 8 Hold and 3 Sell. Targets range from $10 to $26. The latest change came on Nov 5, 2026, when Citigroup lowered its price target on NOV from $21 to $20 and kept a Neutral rating.

The Average Analyst Price Target for NOV is $19.72.

Price Target Range — 13 Quarters

Analyst Consensus — 15 Analysts

4Buy

8Hold

3Sell

Consensus RatingSector Perform# Analysts15Avg. Consensus PT$19.72Upside to Avg. PT+11.5%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for NOV Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 5, 2026	Citigroup	Scott Gruber	PT Cut	Neutral	$21→$20
Oct 29, 2026	Barclays	David Anderson	PT Raise	Underweight	$20→$21
Sep 30, 2026	Citigroup	Scott Gruber	PT Cut	Neutral	$22→$21
Jul 31, 2026	Barclays	David Anderson	PT Cut	Underweight	$21→$20
Jul 30, 2026	Susquehanna	Charles Minervino	PT Raise	Positive	$22→$24
Jul 30, 2026	TD Cowen	Marc Bianchi	PT Raise	Buy	$25→$26
Jul 8, 2026	Susquehanna	Charles Minervino	PT Cut	Positive	$24→$22
Jun 18, 2026	Citigroup	Scott Gruber	PT Raise	Neutral	$20→$22
May 8, 2026	Barclays	David Anderson	Downgrade	Equal-Weight→Underweight	$20→$21
Apr 29, 2026	RBC Capital	Keith Mackey	PT Raise	Sector Perform	$21→$22
Apr 29, 2026	Evercore ISI Group	James West	PT Raise	In-Line	$19→$22
Apr 29, 2026	Susquehanna	Charles Minervino	PT Raise	Positive	$22→$24
Apr 20, 2026	Stifel	Stephen Gengaro	PT Raise	Buy	$21→$23
Apr 15, 2026	Morgan Stanley	Daniel Kutz	PT Raise	Equal-Weight	$18→$20
Apr 14, 2026	RBC Capital	Keith Bachman	Downgrade	Outperform→Sector Perform	$21
Apr 7, 2026	Susquehanna	Charles Minervino	PT Raise	Positive	$21→$22
Mar 4, 2026	Goldman Sachs	Neil Mehta	PT Raise	Sell	$17→$20
Feb 11, 2026	Citigroup	Scott Gruber	PT Raise	Neutral	$17→$20
Feb 9, 2026	BMO Capital	Phillip Jungwirth	PT Raise	Market Perform	$19→$20
Feb 9, 2026	Piper Sandler	Luke Lemoine	PT Raise	Neutral	$17→$18